|
1
|
Yung KW, Yung TT, Chung CY, Tong GT, Liu
Y, Henderson J, Welbeck D and Oseni S: Principles of cancer
staging. Asian Pac J Surg Oncol. 1:1–16. 2015.
|
|
2
|
Lee R, Yeung AW, Hong SE, Brose MS and
Michels DL: Principles of medical oncology. Asian Pac J Surg Oncol.
1:39–46. 2015.
|
|
3
|
Lupichuk S, Tilley D, Kostaras X and Joy
AA: Real-world adjuvant TAC or FEC-D for HER2-negative
node-positive breast cancer in women less than 50 years of age.
Curr Oncol. 23:164–170. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ji Y, Jin HH, Wang MD, Cao WX and Bao JL:
Methylation of the RASSFIA promoter in breast cancer. Genet Mol
Res. 15:156–157. 2016. View Article : Google Scholar
|
|
5
|
Trifa F, Karray-Chouayekh S, Jmal E, Jmaa
ZB, Khabir A, Sellami-Boudawara T, Frikha M, Daoud J and
Mokdad-Gargouri R: Loss of WIF-1 and Wnt5a expression is related to
aggressiveness of sporadic breast cancer in Tunisian patients.
Tumour Biol. 34:1625–1633. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Takahashi H, Kagara N, Tanei T, Naoi Y,
Shimoda M, Shimomura A, Shimazu K, Kim SJ and Noguchi S:
Correlation of methylated circulating tumor DNA with response to
neoadjuvant chemotherapy in breast cancer patients. Clin Breast
Cancer. Jun 16–2016.(Epub ahead of print). PubMed/NCBI
|
|
7
|
Livak KJ and Schmittgen TD: Analysis of
relative geneexpression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kristiansen S, Nielsen D and Sölétormos G:
Detection and monitoring of hypermethylated RASSF1A in serum from
patients with metastatic breast cancer. Clin Epigenetics. 8:352016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Spitzwieser M, Holzweber E, Pfeiler G,
Hacker S and Cichna-Markl M: Applicability of HIN-1, MGMT and
RASSF1A promoter methylation as biomarkers for detecting field
cancerization in breast cancer. Breast Cancer Res. 17:1252015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Han JC, Xu F, Chen N, Qi GB, Wei YJ, Li
HB, Zhang YJ, Li JH, Wang XL, Xu W, et al: Promoter methylations of
RASSF1A and p16 is associated with clinicopathological features in
lung cancers. J Cancer Res Ther. 12:340–349. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
de Groot JS, Moelans CB, Elias SG, Fackler
Jo M, van Domselaar R, Suijkerbuijk KP, Witkamp AJ, Sukumar S, van
Diest PJ and van der Wall E: DNA promoter hypermethylation in
nipple fluid: a potential tool for early breast cancer detection.
Oncotarget. 7:24778–24791. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rauscher GH, Kresovich JK, Poulin M, Yan
L, Macias V, Mahmoud AM, Al-Alem U, Kajdacsy-Balla A, Wiley EL,
Tonetti D, et al: Exploring DNA methylation changes in promoter,
intragenic, and intergenic regions as early and late events in
breast cancer formation. BMC Cancer. 15:8162015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pirouzpanah S, Taleban FA, Mehdipour P and
Atri M: Association of folate and other one-carbon related
nutrients with hypermethylation status and expression of RARB,
BRCA1, and RASSF1A genes in breast cancer patients. J Mol Med
(Berl). 93:917–934. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu D, Wong P, Li W, Vogel CF and Matsumura
F: Suppression of WIF-1 through promoter hypermethylation causes
accelerated proliferation of the aryl hydrocarbon receptor (AHR)
overexpressing MCF10AT1 breast cancer cells. Toxicology.
285:97–103. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xiao C, Wu CH and Hu HZ: LncRNA UCA1
promotes epithelial-mesenchymal transition (EMT) of breast cancer
cells via enhancing Wnt/beta-catenin signaling pathway. Eur Rev Med
Pharmacol Sci. 20:2819–2824. 2016.PubMed/NCBI
|
|
16
|
Li M, Cai H, Yang Y, Zhang J, Sun K, Yan
Y, Qu H, Wang W, Wang J and Duan X: Perichondrium mesenchymal stem
cells inhibit the growth of breast cancer cells via the
DKK-1/Wnt/β-catenin signaling pathway. Oncol Rep. 36:936–944. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jacobsen A, Heijmans N, Verkaar F, Smit
MJ, Heringa J, van Amerongen R and Feenstra KA: Construction and
experimental validation of a Petri net model of Wnt/β-catenin
signaling. PLoS One. 11:e01557432016. View Article : Google Scholar : PubMed/NCBI
|
